| Literature DB >> 30571233 |
Jibo Han1,2,3, Shiju Ye1,2, Chunpeng Zou4, Taiwei Chen1,2, Jingying Wang1, Jieli Li1, Liqin Jiang3, Jianjiang Xu3, Weijian Huang2, Yi Wang1, Guang Liang1.
Abstract
Evidence indicates that Ang II (angiotensin II) activates STAT3 (signal transducer and activator of transcription 3) in cardiomyocytes. However, the mechanisms underlying STAT3 activation and downstream responses are not fully known. In this study, we show that Ang II caused biphasic STAT3 activation in cardiomyocytes. A rapid and early activation was mediated by direct association between TLR4 (toll-like receptor-4) and STAT3. This early activation increased IL-6 (interleukin-6) production, which in turn, induced the second STAT3 activation through the IL-6/gp130 (glycoprotein 130)/JAK2 (Janus-family tyrosine kinases 2) pathway, resulting in unregulated expression of genes for cardiac remodeling. Moreover, STAT3 inhibition or TLR4 knockout in mice protected against Ang II-induced hypertrophy, fibrosis, and cardiac functional deficits. Thus, Ang II-induced STAT3 activation in cardiomyocytes was biphasic, providing a sequential induction of IL-6 and myocardial remodeling genes, respectively. This work supports a novel mechanism on STAT3 activation in Ang II-induced cardiac dysfunction and remodeling.Entities:
Keywords: STAT3 protein; angiotensin II; cardiac hypertrophy; interleukin 6; toll-like receptor
Mesh:
Substances:
Year: 2018 PMID: 30571233 DOI: 10.1161/HYPERTENSIONAHA.118.11860
Source DB: PubMed Journal: Hypertension ISSN: 0194-911X Impact factor: 10.190